CYP24A1 inhibition enhances the antitumor activity of calcitriol. - Wikidata - awgldk - TriplyDB

CYP24A1 inhibition enhances the antitumor activity of calcitriol.

CYP24A1 inhibition enhances the antitumor activity of calcitriol.

http://www.wikidata.org/entity/Q34132307

about

Calcitriol in Combination Therapy for Prostate Cancer: Pharmacokinetic and Pharmacodynamic Interactions Perspectives of differentiation therapies of acute myeloid leukemia: the search for the molecular basis of patients' variable responses to 1,25-dihydroxyvitamin d and vitamin d analogs CYP17 inhibitors for prostate cancer therapy Astemizole synergizes calcitriol antiproliferative activity by inhibiting CYP24A1 and upregulating VDR: a novel approach for breast cancer therapy Novel alkynylphosphonate analogue of calcitriol with potent antiproliferative effects in cancer cells and lack of calcemic activity.Vitamin D: considerations in the continued development as an agent for cancer prevention and therapy.Vitamin D metabolism and action in the prostate: implications for health and disease.VDR activity is differentially affected by Hic-5 in prostate cancer and stromal cells.CYP24A1 exacerbated activity during diabetes contributes to kidney tubular apoptosis via caspase-3 increased expression and activation.Inhibition of protein kinase CK2 reduces Cyp24a1 expression and enhances 1,25-dihydroxyvitamin D(3) antitumor activity in human prostate cancer cells.Inhibitory effects of calcitriol on the growth of MCF-7 breast cancer xenografts in nude mice: selective modulation of aromatase expression in vivo.Vitamin d, sunlight and prostate cancer risk Aberrant DNA methylation of drug metabolism and transport genes in nodular goiter A Functional and Putative Physiological Role of Calcitriol in Patched1/Smoothened Interaction.Vitamin D resistance and colon cancer prevention.Interference with RhoA-ROCK signaling mechanism in autoreactive CD4+ T cells enhances the bioavailability of 1,25-dihydroxyvitamin D3 in experimental autoimmune encephalomyelitis.CYP24 inhibition as a therapeutic target in FGF23-mediated renal phosphate wasting disorders Impaired vitamin D metabolism in CKD High throughput LC-MS/MS method for the simultaneous analysis of multiple vitamin D analytes in serum.Inecalcitol, an analog of 1,25D3, displays enhanced antitumor activity through the induction of apoptosis in a squamous cell carcinoma model system Progesterone potentiates the growth inhibitory effects of calcitriol in endometrial cancer via suppression of CYP24A1.The role of vitamin D in cancer prevention and treatment.The role of vitamin D in cancer prevention and treatment.Vitamin D in cancer chemoprevention.Vitamin D analogue: potent antiproliferative effects on cancer cell lines and lack of hypercalcemic activity.Increased CYP24A1 expression is associated with BRAF(V600E) mutation and advanced stages in papillary thyroid carcinoma.The effect of vitamin D3 and ketoconazole combination on VDR-mediated P-gp expression and function in human colon adenocarcinoma cells: implications in drug disposition and resistance.Vitamin D in combination cancer treatment.Take another CYP: confirming a novel mechanism for "idiopathic" hypercalcemia.The cellular selection between apoptosis and autophagy: roles of vitamin D, glucose and immune response in diabetic nephropathy.Exploring vitamin D metabolism and function in cancer.Dose Escalation of Vitamin D3 Yields Similar Cryosurgical Outcome to Single Dose Exposure in a Prostate Cancer Model.Regulation of CYP27B1 and CYP24A1 hydroxylases limits cell-autonomous activation of vitamin D in dendritic cells.Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.Vitamin D in prostate cancer.

P2860

Q26766242-2A18BC04-6AC3-478C-96C8-CD303B275B82 Q26991440-6F67BC2F-19A9-436A-93A2-CD7DBA8BB4DB Q28298818-E712AC86-9921-44B5-AA67-DE18A315FA9E Q28483692-08337C24-4CC5-44B0-8813-F566F7712BAF Q33598730-85753327-6E50-428A-A6ED-6381032556EC Q33802601-8D4A3117-270F-4F0F-9682-FB32A8721AE2 Q34027269-8D50D6A1-BDC9-48D0-B8A7-BFA77FFA4797 Q34053767-09119708-7425-4ECA-B921-F28C68E546B6 Q34465373-1D9CDB05-E669-4C86-9127-3482C8F155C1 Q34566030-9829C1AA-8A8E-49A3-B57B-89FF8AEE3A79 Q35044178-97ACC4AE-BC89-4F17-952D-3C4FAB6317B2 Q35207472-CBDF42B8-A035-4B88-978C-309EDD022F85 Q35540607-E8DA0516-A9EE-4A85-B171-8372D6BC1B53 Q35925815-62D9D365-0216-41D7-8BD3-6016615E756D Q36061123-D8414405-5467-449C-B111-67F3D1B8F44D Q36204144-C40726D7-537F-48A3-A673-476FE0A436F7 Q36515176-5DA62525-9568-4DE5-9377-30C84352108D Q36668070-B0F956A4-AE1B-4F82-8AFA-2D19275A2A4D Q36710005-F47B7FA9-751D-4AB6-942F-8F6386F66596 Q36724263-0A4E7053-32CB-44BB-91E8-C4D112FB9368 Q37718405-740905E5-3432-47C0-80CF-90FF46A5ABE2 Q37761548-987082AE-073A-4CCA-992B-735B91BC4693 Q38004753-74B9E04B-2A5D-498A-941F-4533B01B636F Q38412880-AFA93098-CB87-4CC2-A08B-4A6CC83A0345 Q38888502-2D829B30-A7D2-4172-970F-D0AD6F0E0291 Q39037968-07E14DD5-C428-437B-94AE-C17B5D05A378 Q39580164-FBAEF647-A1F5-44A5-956F-9FCBA78318C7 Q42427858-D4CE12CE-8DB9-4D6F-BF35-2799CAEA7591 Q42557653-E638979D-E799-4771-82A8-20A0F9B2AFAB Q46593310-2D15CBC0-BB0E-4427-B2FA-BF7B0B48D9D2 Q52587327-416265BD-ADDF-46C2-B39A-33E3BCF2850A Q52685744-D6DC47EE-B322-4F49-AEE0-81EEAE5FDDAA Q53061723-A50DFE08-3DD0-4C07-9C5B-6C0913444A67 Q54268934-503BB6A7-0792-4EE1-8B36-0A7E1EA0479A Q55024961-0BF400EC-57CC-4489-8D57-623751885149

P2860

CYP24A1 inhibition enhances the antitumor activity of calcitriol.

http://www.wikidata.org/entity/Q34132307

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

CYP24A1 inhibition enhances the antitumor activity of calcitriol.

@ast

CYP24A1 inhibition enhances the antitumor activity of calcitriol.

@en

CYP24A1 inhibition enhances the antitumor activity of calcitriol.

@nl

type

label

CYP24A1 inhibition enhances the antitumor activity of calcitriol.

@ast

CYP24A1 inhibition enhances the antitumor activity of calcitriol.

@en

CYP24A1 inhibition enhances the antitumor activity of calcitriol.

@nl

prefLabel

CYP24A1 inhibition enhances the antitumor activity of calcitriol.

@ast

CYP24A1 inhibition enhances the antitumor activity of calcitriol.

@en

CYP24A1 inhibition enhances the antitumor activity of calcitriol.

@nl

P1433

Q34132307-B063BB94-750F-46B6-B0B8-70D7CF84B5CC

P1476

Q34132307-CC9910CA-3A24-4CA2-A8B9-0F5C8271805D

P2093

Q34132307-31C4F608-3475-49EF-B01B-8644E6407EFC

Q34132307-3534F44F-1A93-41ED-BC6A-5F708E701FC1

Q34132307-4C71C857-0FB0-4BB4-8DC5-7977F93685F1

Q34132307-D247FEF8-1340-475E-B294-5006726B9339

Q34132307-D52565D9-F8A7-4854-9783-1E046F8F86F2

Q34132307-E64FA016-BBF5-4A1C-9F6B-969DF692F9B5

Q34132307-F24C93DE-4D87-4B57-A373-61992F7872E6

P2860

Q34132307-04AB8C27-95FE-41FF-8715-3D03A3F6E3B2

Q34132307-0585B7F1-A6CB-49C6-8633-210D6481ED10

Q34132307-0708253D-6718-4996-BEB0-E67F153E46E9

Q34132307-08DA711D-D9F3-4281-BA4B-4096C521FCC4

Q34132307-184FA1C5-A2DE-4FBF-8AEB-1D7368AFD601

Q34132307-1D4427A5-B8B6-4D2D-BB9F-B543562FDDA4

Q34132307-1F9A091B-AFFF-46CB-AA7B-4C4EADD11958

Q34132307-27A0CDC2-423B-4A38-AA5D-89F1B598C15B

Q34132307-2B55D2F1-C74F-4C26-A791-C2C4ECCFA6D1

Q34132307-2EDB9EB7-2D12-461E-B225-BC3D31A91CFA

P304

Q34132307-EFE882ED-449A-44AE-AFCC-0D1B165F2E5F

P31

Q34132307-06279267-8890-4B94-AA7B-65542CF871B1

P356

Q34132307-4410BE93-68B4-4D4F-BDFB-CF380AA365C0

P407

Q34132307-54BACDAC-CECC-4852-9970-DBFF36484AE0

P433

Q34132307-3362C03B-B34C-4161-9836-55755872DCCF

P478

Q34132307-C2A7C6AC-23A9-453D-BEB3-E5CE415B52BD

P577

Q34132307-6EF7C35D-B18B-426F-8332-D1BB44C2357E

P698

Q34132307-5DB59E69-A642-4F9B-BFFE-9201B013DFE3

P932

Q34132307-DF885708-22FC-46C4-9D2F-898A0F82BBBB

P356

P1433

P1476

CYP24A1 inhibition enhances the antitumor activity of calcitriol.

@en

P2093

Candace S Johnson

http://www.w3.org/2001/XMLSchema#string

Donald L Trump

http://www.w3.org/2001/XMLSchema#string

Josephia R Muindi

http://www.w3.org/2001/XMLSchema#string

Kristie L Engler

http://www.w3.org/2001/XMLSchema#string

Rui-Xian Kong

http://www.w3.org/2001/XMLSchema#string

Wei-Dong Yu

http://www.w3.org/2001/XMLSchema#string

Yingyu Ma

http://www.w3.org/2001/XMLSchema#string

P2860

Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis

Clinical significance of the overexpression of the candidate oncogene CYP24 in esophageal cancer

A Phase I trial of calcitriol (1,25-dihydroxycholecalciferol) in patients with advanced malignancy

Role of AIF in caspase-dependent and caspase-independent cell death.

Enzymes involved in the activation and inactivation of vitamin D.

Conventional treatment of hypercalcemia of malignancy.

Hydroxylase enzymes of the vitamin D pathway: expression, function, and regulation.

Secondary hormonal therapies in the treatment of prostate cancer.

In vitro and in vivo evaluation of combined calcitriol and cisplatin in dogs with spontaneously occurring tumors

Role of vitamin D receptor in the antiproliferative effects of calcitriol in tumor-derived endothelial cells and tumor angiogenesis in vivo.

P304

4301-4312

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/EN.2009-1156

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

151

http://www.w3.org/2001/XMLSchema#string

P577

2010-06-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20591973

http://www.w3.org/2001/XMLSchema#string

P932

2940491

http://www.w3.org/2001/XMLSchema#string